论文部分内容阅读
目的观察依达拉奉联合头部亚低温治疗脑出血的临床效果。方法选取2012年1月-2014年6月脑出血患者80例作为研究对象,随机分为依达拉奉联合头部亚低温治疗组(观察组)和常规治疗组(对照组),每组40例,治疗疗程均为2周。比较两组患者神经功能缺损评分情况及临床总有效率。采用SPSS17.0统计学软件进行数据处理,计量资料以(xˉ±s)表示,组间比较采用t检验,组间计数资料比较用χ2检验,P<0.05为差异有统计学意义。结果治疗后观察组和对照组患者神经功能缺损评分分别为(13.28±5.16)和(24.17±5.33)分,均较治疗前下降,且观察组低于对照组,差异有统计学意义(P<0.05);治疗组有效率为87.50%,对照组为62.50%,差异有统计学意义(P<0.05)。结论依达拉奉联合头部亚低温治疗脑出血可获得较好的疗效,适于临床推广应用。
Objective To observe the clinical effect of edaravone combined with head mild hypothermia on cerebral hemorrhage. Methods Eighty patients with cerebral hemorrhage between January 2012 and June 2014 were randomly divided into two groups: edaravone combined with head mild hypothermia (observation group) and conventional treatment group (control group), 40 For example, the treatment course is 2 weeks. Neurological deficit scores and total clinical efficiency were compared between the two groups. SPSS17.0 statistical software for data processing, measurement data to (xˉ ± s), said the comparison between the groups using t test, the comparison between the count data using the χ2 test, P <0.05 for the difference was statistically significant. Results After treatment, the scores of neurological deficits in observation group and control group were (13.28 ± 5.16) and (24.17 ± 5.33) points, respectively, which were lower than those before treatment and the observation group was lower than the control group (P < 0.05). The effective rate was 87.50% in the treatment group and 62.50% in the control group, the difference was statistically significant (P <0.05). Conclusion Edaravone combined with head mild hypothermia in the treatment of intracerebral hemorrhage can get better curative effect, suitable for clinical application.